Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
The Beijing summit did not produce a major agreement between the great powers on the region, but it firmly established that Middle Eastern crises are now deeply tied to the great-power dialogue.